AYTU BIOPHARMA, INC Shareholders' Equity
AYTU BIOPHARMA, INC (AYTU) had Shareholders' Equity of $35.27 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-22
- 2026-06-30: Stockholders' Equity Attributable to Parent $35.27M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $35.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $14.20M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $23.17M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $35.27M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $35.14M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $14.20M 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $23.17M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $18.97M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $34.90M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $30.77M 10-Q · filed 2026-05-13 | |
| 2024-09-30 | $29.83M 10-Q · filed 2026-05-13 | |
| 2024-06-30 | $27.72M 10-K · filed 2026-09-22 | |
| 2024-03-31 | $30.78M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $32.85M 10-Q · filed 2025-05-14 | |
| 2023-09-30 | $32.17M 10-Q · filed 2025-05-14 | |
| 2023-06-30 | $39.36M 10-K · filed 2025-09-23 | |
| 2023-03-31 | $40.91M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $45.82M 10-Q · filed 2024-05-15 | |
| 2022-09-30 | $48.35M 10-Q · filed 2024-05-15 | $53.91M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $44.31M 10-K · filed 2024-09-26 | $46.09M 10-K · filed 2022-09-27 |
| 2022-03-31 | $61.14M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $105.54M 10-Q · filed 2022-05-16 | |
| 2021-09-30 | $111.50M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $137.57M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $143.15M 10-Q · filed 2022-05-16 | $143.15M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $112.69M 10-Q · filed 2022-05-16 | $112.69M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $91.06M 10-Q · filed 2021-11-15 | $91.06M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $95.02M 10-Q · filed 2022-05-16 | $95.02M 10-K · filed 2020-10-06 |
| 2020-03-31 | $85.70M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $17.09M 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $2.32M 10-Q · filed 2021-05-17 | |
| 2019-06-30 | $7.09M 10-Q · filed 2021-05-17 | |
| 2019-03-31 | $16.04M 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $19.90M 10-Q · filed 2020-05-15 | |
| 2018-09-30 | $10.13M 10-Q · filed 2020-05-15 | |
| 2018-06-30 | $13.42M 10-K · filed 2020-10-06 | |
| 2018-03-31 | $12.75M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $3.03M 10-Q · filed 2019-05-14 | |
| 2017-09-30 | $6.35M 10-Q · filed 2019-05-14 | |
| 2017-06-30 | $4.00M 10-K · filed 2019-09-26 | |
| 2017-03-31 | $8.52M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $10.45M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $7.19M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $10.09M 10-K · filed 2018-09-06 | |
| 2016-03-31 | $17.57M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $15.26M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $13.41M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $15.62M 10-K · filed 2017-08-31 | |
| 2015-03-31 | $551.26K 10-Q · filed 2015-05-19 | |
| 2015-02-28 | -$52.92K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | -$44.09K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | -$44.99K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $5.37M 10-K · filed 2016-09-01 | $5.37M 10-Q · filed 2015-05-19 |
| 2014-05-31 | -$36.04K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | -$147.82K 10-Q · filed 2014-04-11 | |
| 2013-11-30 | -$126.22K 10-Q · filed 2014-01-10 | |
| 2013-08-31 | -$110.86K 10-Q · filed 2015-04-15 | |
| 2013-06-30 | $9.81M 10-K · filed 2015-09-28 | |
| 2013-05-31 | -$106.01K 10-Q · filed 2013-06-28 | |
| 2013-02-28 | -$94.83K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | -$82.23K 10-Q · filed 2013-01-14 | |
| 2012-08-31 | -$69.72K 10-K · filed 2014-11-26 | |
| 2012-05-31 | -$54.93K 10-Q · filed 2012-06-26 | |
| 2012-02-29 | -$49.45K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | -$47.63K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | -$35.59K 10-K · filed 2014-11-26 | |
| 2010-08-31 | -$55.61K 10-K · filed 2014-11-26 | |
| 2009-08-31 | -$13.58K 10-K · filed 2014-11-26 | |
| 2008-08-31 | $25.96K 10-K · filed 2014-11-26 | |
| 2007-08-31 | $18.81K 10-K · filed 2014-11-26 | |
| 2006-08-31 | $57.95K 10-K · filed 2014-11-26 | |
| 2005-08-31 | $20.42K 10-K · filed 2014-11-26 | |
| 2005-02-28 | $100.00 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |